MAPS: Open Label Multi-Site Study of Safety and Effects of MDMA-Assisted Therapy for Treatment of PTSD (MP16)

Trial Status:

Completed

Sponsor:

Lykos Therapeutics

ClinicalTrials.gov:

NCT03282123